Prognostic Significance of Preoperative Bowel Obstruction in Stage III Colorectal Cancer

被引:45
作者
Katoh, Hiroshi [1 ]
Yamashita, Keishi [1 ]
Wang, Guoqin [2 ]
Sato, Takeo [1 ]
Nakamura, Takatoshi [1 ]
Watanabe, Masahiko [1 ]
机构
[1] Kitasato Univ, Sch Med, Dept Surg, Kanagawa, Japan
[2] Kitasato Univ, Sch Med, Kitasato Clin Res Ctr, Dept Community Based Perinatal & Emergency Med, Kanagawa, Japan
关键词
LYMPH-NODE RATIO; LONG-TERM PROGNOSIS; COLON-CANCER; TUMOR-CELLS; CARCINOMA; SURVIVAL; SURGERY; RESECTION; DISTENSION; MARKERS;
D O I
10.1245/s10434-011-1625-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies have suggested a detrimental prognostic effect of preoperative obstruction proximal to colorectal cancer (CRC). If such a detrimental effect is preserved in each stage of advanced (stage II or III) CRC, we can identify high-risk patients. We enrolled 641 patients with pathologically confirmed advanced CRC (stage II, n = 207; stage III, n = 434) who had undergone curative resection of the primary lesion. The association of preoperative obstruction with clinicopathologic parameters was evaluated. Kaplan-Meier analysis and Cox proportional hazard models were used to estimate the effect of preoperative obstruction on disease-free survival in each stage. Preoperative obstruction was seen in 63 patients (9.8%) (stage II, n = 16; stage III, n = 47). Multivariable analysis showed that preoperative obstruction was significantly associated with preoperative elevation of carcinoembryonic antigen level in patients with colon cancer (odds ratio = 3.59; P < 0.001), while it was correlated with poor differentiation in patients with rectal cancer (odds ratio = 3.99; P = 0.016). Preoperative obstruction was a significant prognostic factor in stage III CRC (P < 0.001), but not in stage II disease. Multivariable prognostic analysis showed that preoperative obstruction was a remnant independent prognostic factor in stage III CRC. This finding was confirmed by separate analyses of colon and rectal cancer. Preoperative obstruction was associated with systemic recurrence (P = 0.003) rather than peritoneal or local recurrence. These findings suggest that preoperative obstruction may predict worse long-term prognosis in patients with stage III CRC and may be a potential clinical marker to identify patients with high-risk stage III CRC.
引用
收藏
页码:2432 / 2441
页数:10
相关论文
共 40 条
[1]   The predictive value of p53 and p33ING1b in patients with Dukes'C colorectal cancer [J].
Ahmed, I. A. M. ;
Kelly, S. B. ;
Anderson, J. J. ;
Angus, B. ;
Challen, C. ;
Lunec, J. .
COLORECTAL DISEASE, 2008, 10 (04) :344-351
[2]   Circulating tumor cells and bone marrow micrometastasis [J].
Alix-Panabieres, Catherine ;
Riethdorf, Sabine ;
Pantel, Klaus .
CLINICAL CANCER RESEARCH, 2008, 14 (16) :5013-5021
[3]   Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].
Andre, T ;
Boni, C ;
Mounedji-Boudiaf, L ;
Navarro, M ;
Tabernero, J ;
Hickish, T ;
Topham, C ;
Zaninelli, M ;
Clingan, P ;
Bridgewater, J ;
Tabah-Fisch, I ;
de Gramont, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351
[4]   Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study [J].
Andreyev, HJN ;
Norman, AR ;
Cunningham, D ;
Oates, J ;
Dix, BR ;
Iacopetta, BJ ;
Young, J ;
Walsh, T ;
Ward, R ;
Hawkins, N ;
Beranek, M ;
Jandik, P ;
Benamouzig, R ;
Jullian, E ;
Laurent-Puig, P ;
Olschwang, S ;
Muller, O ;
Hoffmann, I ;
Rabes, HM ;
Zietz, C ;
Troungos, C ;
Valavanis, C ;
Yuen, ST ;
Ho, JWC ;
Croke, CT ;
O'Donoghue, DP ;
Giaretti, W ;
Rapallo, A ;
Russo, A ;
Bazan, V ;
Tanaka, M ;
Omura, K ;
Azuma, T ;
Ohkusa, T ;
Fujimori, T ;
Ono, Y ;
Pauly, M ;
Faber, C ;
Glaesener, R ;
de Goeij, AFPM ;
Arends, JW ;
Andersen, SN ;
Lövig, T ;
Breivik, J ;
Gaudernack, G ;
Clausen, OPF ;
De Angelis, P ;
Meling, GI ;
Rognum, TO ;
Smith, R .
BRITISH JOURNAL OF CANCER, 2001, 85 (05) :692-696
[5]  
Baccari P, 2006, HEPATO-GASTROENTEROL, V53, P698
[6]   Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes [J].
Berger, AC ;
Sigurdson, ER ;
LeVoyer, T ;
Hanlon, A ;
Mayer, RJ ;
Macdonald, JS ;
Catalano, PJ ;
Haller, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8706-8712
[7]   Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence [J].
Burdy, G ;
Panis, Y ;
Alves, A ;
Nemeth, J ;
Lavergne-Slove, A ;
Valleur, P .
DISEASES OF THE COLON & RECTUM, 2001, 44 (11) :1682-1688
[8]   Lymph node evaluation and survival after curative resection of colon cancer: Systematic review [J].
Chang, George J. ;
Rodriguez-Bigas, Miguel A. ;
Skibber, John M. ;
Moyer, Virginia A. .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (06) :433-441
[9]  
Cho YB, 2008, HEPATO-GASTROENTEROL, V55, P1288
[10]  
DEANS GT, 1994, ANN ROY COLL SURG, V76, P59